Certified by Founder
Lodge
Baseimmune
start up
United Kingdom
- London, England
- 29/02/2024
- Series A
- $11,402,055
Baseimmune was founded in 2019 as a discovery phase start-up in the antigen discovery and vaccine development field.
- Industry Biotechnology Research
- Website https://www.baseimmune.co.uk/
- LinkedIn https://www.linkedin.com/company/baseimmune/
Related People
Joshua BlightCo Founder
United Kingdom -
ND
Research scientist and biotech co-founder specialising in infectious diseases with a particular interest in mosquito-borne diseases. Skilled in Bioinformatics, Cell Biology, Vaccinology, Immunology, Parasitology and Molecular Biology. Additional experience in Science Communication, Public Engagement and Graphic Design. DPhil in Clinical Medicine, Oxford.
DISA Technologies, Inc. | $33,000,000 | (May 1, 2026)
Jupid | $840,000 | (May 1, 2026)
Dreambase | $3,700,000 | (May 1, 2026)
Creati AI | $20,000,000 | (May 1, 2026)
Manifest OS | $60,000,000 | (May 1, 2026)
Iterative Health | $77,000,000 | (May 1, 2026)
Blomma | $5,000,000 | (May 1, 2026)
Illuminant Surgical | $8,400,000 | (May 1, 2026)
BioOrbit | $13,334,811 | (May 1, 2026)
Parallel Web Systems | $100,000,000 | (Apr 30, 2026)
Fence | $20,000,000 | (Apr 30, 2026)